Personality tied to cardiovascular disease risk with type 2 diabetes
By
HealthDay News
Sep 17, 2024
A lower diligence level was linked to the risk for new cardiovascular disease, but a healthy lifestyle still was beneficial.
Semaglutide reduces risk for MACE in patients with obesity and heart failure
By
Haymarket Media
Aug 28, 2024
MACE, heart failure composite end point, cardiovascular death and all-cause death all improved with semaglutide for patients with versus without heart failure.